India Medical Robots Market to Reach USD 365 Million by 2032, Growing at a CAGR of 17.04% During 2026–2032

The India Medical Robots Market was valued at USD 129 million in 2025, reached USD 142 million in 2026, and is projected to grow to USD 365 million by 2032, expanding at a compound annual growth rate (CAGR) of 17.04% during the forecast period 2026–2032.

According to the World Health Organization, nearly 63% of all deaths in India are attributable to non-communicable diseases, including cardiovascular disease, cancer, and diabetes, sustaining clinical demand for precision surgical interventions where robotic platforms deliver measurably superior patient outcomes. Furthermore, the Indian Council of Medical Research (ICMR) reported 1,533,055 estimated new cancer cases in India for 2024, a volume that directly accelerates the adoption of robotic-assisted minimally invasive surgery systems across tertiary hospitals.

Additionally, the Government of India approved USD 3.46 billion in allocations under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) for 2021–22 to 2025–26. The Union Budget 2025–26 raised the total healthcare allocation by approximately 11% to USD 10.46 billion, with PM-ABHIM alone receiving a 40% increase over the prior year, directly expanding hospital networks where AI-powered medical robots and surgical navigation systems are deployed.

In parallel, India's medical robotics sector is undergoing a sustained shift toward AI-guided platforms that embed real-time decision-support, patient-specific 3D surgical planning, and precision instrument control directly into the operating workflow, broadening robotic surgery demand beyond premium urban chains into public institutions and Tier 2 cities. Surgical robots account for by product type, driven by their application across urology, oncology, cardiac surgery, gynecology, and general surgery. By mobility, fixed robotic systems dominate, supported by the infrastructure commitments of India’s large tertiary hospital chains.

Regionally, South India emerges as the leading regional market, anchored by the highest concentration of JCI and NABH-accredited multi-specialty hospital chains, including Apollo Hospitals (Chennai), Narayana Health (Bengaluru), CARE Hospitals (Hyderabad), and Manipal Hospitals (Bengaluru). Tamil Nadu allocated USD 2.12 billion to healthcare in its 2024–25 state budget, an 8.2% increase over the prior year. As domestic manufacturing scales under the Government’s PLI Scheme for Medical Devices and AI integration deepens across robotic platforms, the India Medical Robots Market is positioned for sustained double-digit growth through 2032, as stated in the recent report “India Medical Robots Market Analysis, 2026”.

India Medical Robots Market Highlights

The India Medical Robots Market was valued at USD 129 million in 2025, reached USD 142 million in 2026, and is projected to grow to USD 365 million by 2032, registering a CAGR of 17.04%.
Surgical robots dominated the market by product type, accounting for approximately 48% of total revenue in 2025, driven by increasing adoption of robotic-assisted minimally invasive surgical procedures across urology, oncology, cardiac surgery, and gynecology.
By mobility, fixed robotic systems held the largest market share of approximately 75%, owing to widespread deployment across surgical, diagnostic, and hospital-based healthcare applications at India’s leading tertiary chains.
South India emerged as the leading regional market, capturing approximately 40% of total revenue, supported by advanced healthcare infrastructure and higher penetration of robotic-assisted medical technologies across Chennai, Bengaluru, and Hyderabad.
The market is moderately consolidated, with the top five players collectively accounting for around 20% of total market revenue, reflecting competition from both global leaders and domestic innovators.